Breast Cancer Update cover image

Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series

Breast Cancer Update

00:00

Can I Use Cappy Vissertib in Tumors?

Cappy Vissertib was approved for oral use. Can you kind of put this in a class of agents where we've seen tolerability issues? You mentioned Cappy's Estrin, another serge involved. There's tons of trials. It seems like there's tons of agents. So I guess we'll just have to deal with it as they come out and the data comes out and they get approved.

Play episode from 49:47
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app